What is CD4+CD56+ malignancy and how should it be treated?
D000951:Antigens, Neoplasm; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015704:CD4 Antigens; D019002:CD56 Antigen; D019337:Hematologic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007694:Killer Cells, Natural / Q000473:pathology*; D015458:Leukemia, T-Cell / Q000473:pathology / Q000628:therapy; D016399:Lymphoma, T-Cell / Q000473:pathology / Q000628:therapy; D016019:Survival Analysis; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D015704:CD4 Antigens; D019002:CD56 Antigen